[Early and late results of coronary artery bypass grafting and percutaneous transluminal coronary angioplasty]. 1992

K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
Division of Cardiovascular Surgery and Cardiology, Toranomon Hospital, Tokyo, Japan.

The indication of coronary artery bypass grafting (CABG) and percutaneous transluminal coronary angioplasty (PTCA) for coronary artery disease, especially for multivessel disease, remains controversial. We examined the characteristics and outcomes of the CABG group (799 consecutive patients) and the PTCA group (944 patients) from 1984 to 1991. The proportion of 3-vessel and left main disease in the CABG group was 77% and that of single-vessel in the PTCA group was 92%. The characteristics between 2 groups were distinct. But the results were good respectively. The occurrence of hospital death was similar (1.3% vs 0%). The early graft patency rate in the CABG group was 91% and primary success rate in the PTCA group was 90%. And over a 5-year follow-up the cumulative survival rate of 3-vessel disease undergoing CABG and single-vessel disease patients undergoing PTCA was 96% versus 98%, respectively. It is concluded that PTCA is suitable for single-vessel and 2-vessel without totally occluded artery disease patients, whereas CABG for other multivessel disease patients.

UI MeSH Term Description Entries
D003327 Coronary Disease An imbalance between myocardial functional requirements and the capacity of the CORONARY VESSELS to supply sufficient blood flow. It is a form of MYOCARDIAL ISCHEMIA (insufficient blood supply to the heart muscle) caused by a decreased capacity of the coronary vessels. Coronary Heart Disease,Coronary Diseases,Coronary Heart Diseases,Disease, Coronary,Disease, Coronary Heart,Diseases, Coronary,Diseases, Coronary Heart,Heart Disease, Coronary,Heart Diseases, Coronary
D005500 Follow-Up Studies Studies in which individuals or populations are followed to assess the outcome of exposures, procedures, or effects of a characteristic, e.g., occurrence of disease. Followup Studies,Follow Up Studies,Follow-Up Study,Followup Study,Studies, Follow-Up,Studies, Followup,Study, Follow-Up,Study, Followup
D001026 Coronary Artery Bypass Surgical therapy of ischemic coronary artery disease achieved by grafting a section of saphenous vein, internal mammary artery, or other substitute between the aorta and the obstructed coronary artery distal to the obstructive lesion. Aortocoronary Bypass,Bypass, Coronary Artery,Bypass Surgery, Coronary Artery,Coronary Artery Bypass Grafting,Coronary Artery Bypass Surgery,Aortocoronary Bypasses,Artery Bypass, Coronary,Artery Bypasses, Coronary,Bypass, Aortocoronary,Bypasses, Aortocoronary,Bypasses, Coronary Artery,Coronary Artery Bypasses
D015906 Angioplasty, Balloon, Coronary Dilation of an occluded coronary artery (or arteries) by means of a balloon catheter to restore myocardial blood supply. Angioplasty, Coronary Balloon,Angioplasty, Transluminal, Percutaneous Coronary,Coronary Angioplasty, Transluminal Balloon,Percutaneous Transluminal Coronary Angioplasty,Balloon Dilation, Coronary Artery,Transluminal Coronary Balloon Dilation,Angioplasties, Coronary Balloon,Balloon Angioplasties, Coronary,Balloon Angioplasty, Coronary,Coronary Balloon Angioplasties,Coronary Balloon Angioplasty
D015996 Survival Rate The proportion of survivors in a group, e.g., of patients, studied and followed over a period, or the proportion of persons in a specified group alive at the beginning of a time interval who survive to the end of the interval. It is often studied using life table methods. Cumulative Survival Rate,Mean Survival Time,Cumulative Survival Rates,Mean Survival Times,Rate, Cumulative Survival,Rate, Survival,Rates, Cumulative Survival,Rates, Survival,Survival Rate, Cumulative,Survival Rates,Survival Rates, Cumulative,Survival Time, Mean,Survival Times, Mean,Time, Mean Survival,Times, Mean Survival

Related Publications

K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
January 1989, The Journal of thoracic and cardiovascular surgery,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
February 1992, [Zasshi] [Journal]. Nihon Kyobu Geka Gakkai,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
January 1997, Scandinavian cardiovascular journal : SCJ,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
October 1990, The American journal of cardiology,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
September 1985, The American journal of cardiology,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
January 1994, The International journal of risk & safety in medicine,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
February 1987, The Journal of thoracic and cardiovascular surgery,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
January 1984, The Journal of thoracic and cardiovascular surgery,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
March 1992, Kyobu geka. The Japanese journal of thoracic surgery,
K Fuse, and S Nakanishi, and S Nishiyama, and T Iwase, and Y Naruse, and H Konishi, and T Kobayashi
September 1989, Kyobu geka. The Japanese journal of thoracic surgery,
Copied contents to your clipboard!